In this chapter, selected immunopharmacological targets that are currently part of multiple
sclerosis (MS) therapy are described, with particular attention paid to translational aspects in …

Anti-CD20 B cell depleting therapies have demonstrated that B cells are important drivers of
disease progress in Multiple Sclerosis, although the pathogenic mechanisms are not well …

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system
involving inflammation, demyelination, and axonal degeneration. Remarkable advances …

B cell depleting therapies have been effective in the treatment of Multiple Sclerosis (MS), yet
to date little is known about how B cells promote disease pathogenesis. B cells can be found …

Characterising the Role of B cells in Gastric Cancer Page 1 Characterising the Role of B cells
in Gastric Cancer Lokman Pang Bachelor of Science (with Honours) Submitted in Total …

Los oligodendrocitos son las células gliales encargadas de la mielinización de los axones y
desempeñan un papel fundamental en el desarrollo y la correcta transmisión de los …

Currently, human Bregs have been identified at different stages of B cell development and
consist of various B cell surface markers; these include CD19+CD24hiCD38hi immature …

Multiple sclerosis (MS, disseminate encephalomyelitis, ICD-10: G35) is a chronic primarily
inflammatory disease of the central nervous system (CNS) in which myelin and axons are …

Multiple sclerosis is a complex disease with no definitive cause or cure. Positive clinical
trials such as those with anti-CD20 and negative clinical trials such as those with TACI-Ig–all …

The article presents the results of the analysis of the parameters of adaptive cellular
immunity, in particular, the immunophenotypic features of peripheral blood B-lymphocytes in …